Wipfli Financial Advisors’s Globus Medical GMED Stock Holding History

Wipfli Financial Advisors’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$50K	Buy	+842	New	+$50.7K	﹤0.01%	1077

Other funds holding GMED

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wipfli Financial Advisors's GMED Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in Globus Medical (GMED) in Q3 2022: 842 shares worth $50K. The stake represents ﹤0.01% of the portfolio and ranks #1077 among its holdings.

370 funds tracked by Wall St. Rank hold GMED as of Q3 2022.

Wipfli Financial Advisors held 842 shares of Globus Medical worth $50K as of Q3 2022.
Globus Medical was a new Wipfli Financial Advisors position in Q3 2022.
Globus Medical made up ﹤0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #1077 holding.
370 funds tracked by Wall St. Rank held Globus Medical as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.